Heath Penland
Psychiatry · Huntsville, ALNPI 1649293630
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 565 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 565 payments — averaging $19.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Bausch Health US, LLC$882
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$775
- Takeda Pharmaceuticals U.S.A., Inc.$655
- Axsome Therapeutics, Inc.$625
- plus $5K from 22 others
What the payments were for
- Food & beverage$10,694100%
- Education$490%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 89 | $1,567 |
| Otsuka America Pharmaceutical, Inc. | 69 | $1,405 |
| Bausch Health US, LLC | 50 | $882 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 37 | $775 |
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $655 |
| Axsome Therapeutics, Inc. | 38 | $625 |
| Alkermes, Inc. | 23 | $606 |
| Almatica Pharma LLC | 25 | $553 |
| Corium, LLC | 29 | $484 |
| Teva Pharmaceuticals USA, Inc. | 25 | $450 |
| Lundbeck LLC | 23 | $429 |
| Vanda Pharmaceuticals Inc. | 15 | $386 |
| Johnson & Johnson | 19 | $341 |
| Neos Therapeutics, LP | 17 | $296 |
| Supernus Pharmaceuticals, Inc. | 7 | $177 |
| Eisai Inc. | 10 | $149 |
| Ironshore Pharmaceuticals Inc. | 7 | $143 |
| Merck | 8 | $139 |
| Tris Pharma Inc | 7 | $134 |
| Adlon Therapeutics L.p. | 8 | $125 |
| Idorsia Pharmaceuticals US Inc | 7 | $125 |
| Avanir Pharmaceuticals, Inc. | 5 | $94 |
| Shire North American Group Inc | 3 | $54 |
| Neurocrine Biosciences, Inc. | 2 | $45 |
| Jazz Pharmaceuticals Inc. | 2 | $38 |
| Noven Therapeutics, LLC | 1 | $24 |
| Neuronetics, Inc. | 2 | $22 |
| Alfasigma USA, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,743 in reported general payments places this provider in the 90th percentile of 400 psychiatry providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 14 | $31,000 |
| Rivastigmine | 14 | $2,652 |
| Lisdexamfetamine Dimesylate | 12 | $1,975 |
| Clozapine | 12 | $1,534 |
| Duloxetine Hcl | 55 | $1,438 |
| Bupropion XlBupropion Hcl | 43 | $1,396 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 46 | $1,120 |
| Methylphenidate Hcl | 34 | $1,060 |
| Bupropion Hcl SrBupropion Hcl | 15 | $858 |
| Aripiprazole | 27 | $722 |
| Trazodone Hcl | 26 | $663 |
| Lamotrigine | 68 | $653 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 19 | $589 |
| Quetiapine Fumarate | 67 | $572 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 20 | $534 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,567 | $31,00014 claims |
| Almatica Pharma LLCSertraline Hcl | $553 | $17723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 400 psychiatry providers in Alabama.
Other psychiatry in Huntsville
- Scariya KumaramangalamHuntsville$440K
- Glenn ArchibaldHuntsville$24K
- Sofia AeschlimannHuntsville$18K
- Quratulain AghaHuntsville$10K
- Armand SchachterBirmingham$758K
- Stephen HughesBirmingham$683K
- Leesha Ellis CoxBirmingham$653K
- Godehard OepenBirmingham$516K
- Mark HaygoodMobile$348K
- Lori DavisTuscaloosa$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.